Full Event Guide

Download the Brand New Event Guide for 2024 to Discover:

  • Novel technologies enabling precise small and large DNA fragment insertion
  • How to improve the robustness of your nonclinical and clinical safety packages
  • Delivery technology improvements enabling cell- and tissue- specific delivery
  • The latest regulatory insights to progress to the clinic and gain a platform technology designation
  • How to secure your IP, ensure freedom-to-operate, and structure a licensing deal
image - 2024-11-11T161930.809

Having issues downloading? Click here to request a copy of the event guide!

Snapshot of Companies Attending

Moderna Alexion pharmaceuticals MaxCyte Vertex Pharmaceuticals Editas Medicine Bristol Myers Squibb Intellia Therapeutics Precision BioSciences Serum Institute of India Incisive Genetics GentiBio Life Edit Therapeutics ExoVectory Legend Biotech Nitto Denko Corporation Apellis Pharmaceuticals Locke Lord
Jeffrey Cehelsky - Intellia

“This summit affords leaders a place to come together for education and information sharing. Together, the promise of this technology is our responsibility to safely deliver to the patients and families that we aim to serve.”

- Jeffrey Cehelsky, Vice President, Development Operations at Intellia Therapeutics